NovaBridge Biosciences Cash Flow Quality Index
NovaBridge Biosciences cash flow quality index. NovaBridge Biosciences (NBP) has a Cash Flow Quality Index of -19.06x as of December 2020. Operating cash flow of $-232.84 Million is below net income of $12.22 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial agility of NovaBridge Biosciences to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of NovaBridge Biosciences (2020–2020)
Cash flow quality index of NovaBridge Biosciences from 2020 to 2020. Historical Cash Flow Quality Index for NovaBridge Biosciences across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can NovaBridge Biosciences service its debt to assess how comfortably operating cash covers total debt obligations.
NovaBridge Biosciences Cash Flow Quality Index by Year (2020–2020)
NovaBridge Biosciences cash flow quality index by year from 2020 to 2020. Year-by-year earnings quality comparison for NovaBridge Biosciences. For the full cash flow conversion analysis, see NovaBridge Biosciences cash conversion from operations.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 0.92x | $433.56 Million | $470.92 Million | — |